Skip to content

The Impact of Synergies of Indoor Air Pollutants on Childhood Health and Wellbeing

The Impact of Synergies of Indoor Air Pollutants on Childhood Health and Wellbeing

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05105386
Acronym
SynAir-Child
Enrollment
3000
Registered
2021-11-03
Start date
2023-09-30
Completion date
2027-09-30
Last updated
2021-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood, Childhood Asthma, Environmental Exposure, Pollution; Exposure

Brief summary

To quantify health effects of synergizing chemical and biological pollutants in a targeted population setting, i.e., school-aged children. Indoor air pollutants will be monitored within the classrooms with high end sensors. Exposure data from additional sources (outdoor, home, transports) will be obtained. Health outcomes will be assessed prospectively using validated medical procedures and real-time tracking with mobile health (mHealth) equipment and a gamified computer app.

Detailed description

Communication with individual schools and families representing diverse cultural and socioeconomic backgrounds, will be conducted and formal participation consents obtained. The target population will include healthy children and be enriched for children with respiratory allergies and asthma. Provision of instructions, training for participation and baseline assessments of respiratory, immune, and mental health using questionnaires and relevant physiological measurements (e.g spirometry, FeNO), will be performed. Sensors will be positioned and cross-checked for functionality.Health data from the cohort will be monitored by a specifically designed gamified application, as well as by state-of-the-art wearable tracking technology. The app will capture input from the participants at large, while the trackers will accurately, continuously, and remotely, identify personalized patterns of all day activity status, heart rate, oxygen saturation, temperature, blood pressure, sleep, respiratory rate, and mechano-acoustic breathing sounds signatures. Sentinel data will be processed in Work Package 6 and integrated in the SynAir-G autonomous sensing platform. Children will be prospectively followed-up for a school year. Investigators will regularly visit schools to keep sensors running and collect materials. Real-time tracking will be coupled with regular communication and face-to-face visits for health outcome assessments. Devices will be positioned in selected locations. The cohort will also provide the setting for establishing indoor and outdoor interactions, dose-responses in real life, and health outcome data for integration and synergy analyses.

Interventions

DEVICESynAir-Child

Monitor the indoor pollutants and their effect on children well being

Sponsors

National and Kapodistrian University of Athens
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
8 Years to 9 Years

Inclusion criteria

1. Students of primary schools aged 8-9 years. 2. The subject and/or legal custodian have the verbal, writing and mental ability to understand the intent and character of the study. 3. Written informed consent from the child's parents/guardian's

Exclusion criteria

Unwilling to use the application and follow the procedures of the protocol

Design outcomes

Primary

MeasureTime frameDescription
Cardiovascular metricsOne yearWearables
Height and weightOne yearHeight in cm and weight in kg will be combined to report BMI (kg/m\^2)
Respiratory, mental healthOne yearQuestionnaires
Immune healthOne yearRNA Sequency/CRP
Oxidative stressOne yearDNA damage levels in blood cells
Lung function andOne yearSpirometry
Airway inflammationOne yearExhaled nitric oxide
Exhaled volatile compoundsOne yearBreath biopsy

Contacts

Primary ContactPARASKEVI XEPAPADAKI, Assoc. Prof.
vickyxepapadaki@gmail.com2132009160
Backup ContactNIKOLAOS G PAPADOPOULOS, Professor
ngpoffice@allergy.gr2107776964

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026